SNN Stock May Gain Following the Co-Marketing Deal With JointVue

Company Developments - Smith & Nephew (SNN) has signed a co-marketing agreement with JointVue for the OrthoSonic 3D Surgery Planning Technology, the only ultrasound device for 3D preoperative planning currently available [1] - JointVue's technology enables personalized surgical plans using SNN's CORI Surgical System for robotic-assisted knee arthroplasty, potentially improving patient satisfaction and operating room efficiency [2] - Following the announcement, SNN shares increased by 1.2% to $28.62 [3] - The integration of JointVue's technology is expected to enhance the imaging modalities available for pre-operative robotic planning, catering to the growing Ambulatory Surgery Center (ASC) market [7] Market Trends - The demand for robotic-assisted knee surgery solutions is increasing, driven by the need for personalized surgical approaches and advanced planning tools [4] - SNN shares have risen by 20.3% over the past six months, outperforming the industry’s 13.1% increase and the S&P 500's 15.9% rise [5] - The global surgical robots market is projected to grow at a rate of 9.5% from 2024 to 2030, with a current market size of $3.92 billion [10] Industry Insights - Factors driving market growth include a shortage of physicians, increased adoption of automated surgical instruments, and a rise in bone degenerative diseases leading to more hip and knee replacement surgeries [11] - The combination of JointVue's OrthoSonic technology with SNN's CORI Surgical System is positioned as an ideal solution for ASCs, where operating room space is often limited [5][6]